Published by Iain Gilbert on 1st September 2026
(Sharecast News) - Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III after reporting positive Phase II results at the OPTIONS XIII influenza conference.
URL: http://www.digitallook.com/dl/news/story/36179172/...